Archive for the ‘Addex Pharmaceuticals’ Category

Merck/Addex Pharmaceuticals – Top 10 biotech deal terminations of 2011

December 19th, 2011 John Carroll

Partners: Merck/Addex PharmaceuticalsBased: $MRK – Whitehouse Station, NJ; $ADXN – GenevaTermination date: July 2011Length: 3.5 yearsDeal: $702 millionProgram: ADX63365, an mGluR4 positive allosteric modulator (PAM) for schizophrenia, and backup candid…

Posted in Addex Pharmaceuticals, Blog, Companies, Diagnostics, Funding, Medical Devices, Medical Supply, Merck, Pharmaceuticals, Startups, Universities, Videos Tags: Comments Off
Read More »